Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  BGI Genomics Co., Ltd.    300676   CNE100003449

BGI GENOMICS CO., LTD.

(300676)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BGI Genomics : China's BGI defends COVID-19 test kit after Swedish criticism

08/26/2020 | 09:37am EST

China's BGI Genomics said on Wednesday its coronavirus testing kit has "relatively high accuracy", a day after Sweden said about 3,700 people received false positive results due to a fault in the company's product.

Sweden health authorities said on Tuesday that the test kit, which has been widely exported to other countries, could not distinguish between very low levels of the virus and a negative result.

BGI said devices sensitive enough to detect a smaller amount of the virus would deliver positive results, while less sensitive products would return negative results.

"The company's test has relatively high accuracy and received positive clinical assessment," it said.

The global surge in demand for coronavirus test kits has allowed BGI to expect its net profit to jump about eight times in the first half of this year.

But the purchase of test kits from BGI, which has grown into one of the world's largest genomics companies over the past two decades, has been controversial in some countries.

(Reporting by Roxanne Liu in Beijing and Miyoung Kim in Singapore; Editing by Nick Macfie)


© Reuters 2020
All news about BGI GENOMICS CO., LTD.
09/23China's BGI wins 1.5 million coronavirus test kit order from Ethiopia
RE
09/23China's BGI wins 1.5 mln coronavirus test kit order from Ethiopia
RE
08/27BGI GENOMICS : WHO says it is in talks with China's BGI on test kit after Swedis..
RE
08/26BGI GENOMICS : China's BGI defends COVID-19 test kit after Swedish criticism
RE
08/24BGI GENOMICS CO., LTD. : half-yearly earnings release
08/05SPECIAL REPORT : COVID opens new doors for China's gene giant
RE
07/22BGI GENOMICS : Chinese genetics company BGI denies U.S. human rights accusations
RE
07/21U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
07/20U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
07/14BGI GENOMICS : China's BGI forecasts 700% jump in first-half profit due to COVID..
RE
More news
Financials
Sales 2020 8 985 M 1 367 M 1 367 M
Net income 2020 3 530 M 537 M 537 M
Net Debt 2020 - - -
P/E ratio 2020 14,5x
Yield 2020 0,15%
Capitalization 50 542 M 7 686 M 7 688 M
Capi. / Sales 2020 5,63x
Capi. / Sales 2021 9,43x
Nbr of Employees -
Free-Float 100,0%
Chart BGI GENOMICS CO., LTD.
Duration : Period :
BGI Genomics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BGI GENOMICS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price
Last Close Price 127,60 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Ye Yin General Manager & Director
Jian Wang Chairman
Song Gang Li Chairman-Supervisory Board
Yi Qing Chen Chief Financial Officer
Jun Wang Director
Sector and Competitors
1st jan.Capitalization (M$)
BGI GENOMICS CO., LTD.85.74%7 809
EXACT SCIENCES CORPORATION25.29%18 427
GUARDANT HEALTH, INC.44.15%11 261
INVITAE CORPORATION190.45%8 278
ADAPTIVE BIOTECHNOLOGIES CORPORATION53.18%6 268
IOVANCE BIOTHERAPEUTICS, INC.37.07%5 565